Computer security for the home and small office

por Greene, Thomas
Publicado 2004

Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation

por Vedula, S Swaroop, Goldman, Palko S, Rona, Ilyas J, Greene, Thomas M, Dickersin, Kay
Publicado 2012

A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937

por Benn, Paul D., Zhang, Ying, Kahl, Lesley, Greene, Thomas J., Bainbridge, Veronica, Fishman, Cindy, Wen, Bo, Gartland, Martin
Publicado 2023

Utilizing Propensity Score Analyses in Prehospital Blood Product Transfusion Studies: Lessons Learned and Moving Toward Best Practice

por Greene, Thomas J, DeSantis, Stacia M, Fox, Erin E, Wade, Charles E, Holcomb, John B, Swartz, Michael D
Publicado 2018

Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults

por Pene Dumitrescu, Teodora, Joshi, Samit R., Xu, Jianfeng, Greene, Thomas J., Johnson, Mark, Butcher, Laurie, Zimmerman, Eric, Webster, Lindsey, Pham, Theresa T., Lataillade, Max, Min, Sherene
Publicado 2021

Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells

por Wang, Shu, Malebari, Azizah M., Greene, Thomas F., Kandwal, Shubhangi, Fayne, Darren, Nathwani, Seema M., Zisterer, Daniela M., Twamley, Brendan, O’Boyle, Niamh M., Meegan, Mary J.
Publicado 2023

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women

por Pene Dumitrescu, Teodora, Greene, Thomas J., Joshi, Samit R., Xu, Jianfeng, Johnson, Mark, Halliday, Fiona, Butcher, Laurie, Zimmerman, Eric, Webster, Lindsey, Pham, Theresa T., Lataillade, Max, Min, Sherene
Publicado 2021

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

por Joshi, Samit R., Fernando, Disala, Igwe, Stephanie, McKenzie, Litza, Krishnatry, Anu S., Halliday, Fiona, Zhan, Joyce, Greene, Thomas J., Xu, Jianfeng, Ferron‐Brady, Geraldine, Lataillade, Max, Min, Sherene
Publicado 2020

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells

por Wang, Shu, Malebari, Azizah M., Greene, Thomas F., O’Boyle, Niamh M., Fayne, Darren, Nathwani, Seema M., Twamley, Brendan, McCabe, Thomas, Keely, Niall O., Zisterer, Daniela M., Meegan, Mary J.
Publicado 2019

Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4

por Malebari, Azizah M., Wang, Shu, Greene, Thomas F., O’Boyle, Niamh M., Fayne, Darren, Khan, Mohemmed Faraz, Nathwani, Seema M., Twamley, Brendan, McCabe, Thomas, Zisterer, Daniela M., Meegan, Mary J.
Publicado 2021